Literature DB >> 3853219

Methicillin-resistant Staphylococcus aureus at children's hospitals in the United States.

W R Jarvis, C Thornsberry, J Boyce, J M Hughes.   

Abstract

Although methicillin-resistant Staphylococcus aureus (MRSA) has emerged as an important pathogen in hospitalized adults in the United States, reports of MRSA in pediatric patients have been infrequent. To determine the frequency at which MRSA is isolated from children, we surveyed the directors of microbiology at all acute care children's hospitals in the United States, and 57 of 67 (85%) laboratory directors responded to a mailed questionnaire. Those not testing S. aureus for methicillin susceptibility were excluded from the analysis. Of 53 (57%) laboratory directors 30 reported that MRSA had been isolated from patients in their hospitals. Between 1973 and 1981 the proportion of hospitals isolating MRSA increased significantly; 1 of 53 hospitals reported MRSA in 1973 compared to 20 of 53 hospitals in 1981 (P less than 0.001). Large hospitals (greater than or equal to 200 beds) reported MRSA isolates more frequently than did small hospitals (less than 200 beds) (P = 0.007). No association was found between the isolation of MRSA and the presence of burn or intensive care units, residency training programs or rotation of residents to other hospitals. MRSA isolation varied by standard metropolitan statistical area and geographic region. These data show that the isolation of MRSA is increasing in frequency in pediatric patients and that the reporting of MRSA from children's hospitals varies by hospital size, standard metropolitan statistical area and region. Since MRSA causes significant morbidity and mortality, further studies are necessary to identify the risk factors for MRSA infections and to develop effective control measures.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3853219     DOI: 10.1097/00006454-198511000-00011

Source DB:  PubMed          Journal:  Pediatr Infect Dis        ISSN: 0277-9730


  6 in total

Review 1.  Modification of penicillin-binding proteins as mechanisms of beta-lactam resistance.

Authors:  F Malouin; L E Bryan
Journal:  Antimicrob Agents Chemother       Date:  1986-07       Impact factor: 5.191

2.  Efficacy of mupirocin in methicillin-resistant Staphylococcus aureus burn wound infection.

Authors:  H Rode; D Hanslo; P M de Wet; A J Millar; S Cywes
Journal:  Antimicrob Agents Chemother       Date:  1989-08       Impact factor: 5.191

3.  Radiological findings of community-acquired methicillin-resistant and methicillin-susceptible Staphylococcus aureus pediatric pneumonia in Hawaii.

Authors:  Guliz Erdem; Lora Bergert; Kyra Len; Marian Melish; Kevin Kon; Robert DiMauro
Journal:  Pediatr Radiol       Date:  2010-05-14

4.  Ciprofloxacin-resistant methicillin-resistant Staphylococcus aureus in New York health care facilities, 1988. The New York MRSA Study Group.

Authors:  L D Budnick; S Schaefler
Journal:  Am J Public Health       Date:  1990-07       Impact factor: 9.308

5.  Latex agglutination-negative methicillin-resistant Staphylococcus aureus recovered from neonates: epidemiologic features and comparison of typing methods.

Authors:  A R Wanger; S L Morris; C Ericsson; K V Singh; M T LaRocco
Journal:  J Clin Microbiol       Date:  1992-10       Impact factor: 5.948

6.  Genotyping of Methicillin Resistant Staphylococcus aureus Strains Isolated from Hospitalized Children.

Authors:  Mouna Ben Nejma; Abderrahmen Merghni; Maha Mastouri
Journal:  Int J Pediatr       Date:  2014-10-22
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.